Eliav Barr

20.1k citations
77 papers · 11.0k · 6 hit papers · h-index 43

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
  • Epidemiology top 0.1%
    • Cervical Cancer and HPV Research
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Cervical Cancer and HPV Research 32
    • Hepatitis B Virus Studies 12
    • Liver Disease Diagnosis and Treatment 4
    • Hepatitis C virus research 26

Eliav Barr

76 papers receiving 10.3k citations

Eliav Barr's Hit Papers

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study 2015 · 493 citations
4930+8+16Years since publication4008001.2k

Peers

Eliav Barr
Comparison fields: 5 of 140
  • Hepatology 1.9k
  • Epidemiology 7.2k
  • Microbiology 515
  • Health 476
  • Immunology 1.2k
Replace Mireia Díaz with:
Mireia Díaz Spain
Catherine de Martel France
Gary M. Clifford France
Lindsey R. Baden United States
Mark J. DiNubile United States
Nicola P. Klein United States
R. Palmer Beasley United States
Howard D. Strickler United States
David Jenkins United Kingdom
Stephen Shiboski United States
Eliav Barr relative to Mireia Díaz Spain Mireia Díaz's profile →
Citations per field
00.5×1.5×2.4×
Mireia Díaz · 1×
Citations per year

Countries citing papers authored by Eliav Barr

Since Specialization
Citations

This map shows the geographic impact of Eliav Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliav Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliav Barr more than expected).

Fields of papers citing papers by Eliav Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliav Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliav Barr. The network helps show where Eliav Barr may publish in the future.

Co-authors

The 25 scholars most cited alongside Eliav Barr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eliav Barr Line = papers co-authored together Eliav Barr links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
Hit paper breakdown →
20071458
2
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Hit paper breakdown →
20021312
3
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Hit paper breakdown →
2011883
4
ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES
Hit paper breakdown →
2006678
5
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Hit paper breakdown →
2015493
6 2009409
7
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
Hit paper breakdown →
2015400
8 2006383
9 2009382
10 1995379
11 2006371
12 2001275
13 2007248
14 1991245
15 2015230
16 2005214
17 2016128
18 2007115
19 2007114
20 2015113

About Eliav Barr

Eliav Barr is a scholar working on Epidemiology, Hepatology, Cardiology and Cardiovascular Medicine, Infectious Diseases and Molecular Biology, having authored 77 papers that have together received 11.0k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (32 papers), Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (12 papers), HIV/AIDS drug development and treatment (7 papers), Immunotherapy and Immune Responses (6 papers), Liver Disease Diagnosis and Treatment (4 papers), Acute Myocardial Infarction Research (4 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (7.2k citations), Microbiology (515 citations), Health (476 citations) and Immunology (1.2k citations). Eliav Barr has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Cosette M. Wheeler, Laura A. Koutsky, Kathrin U. Jansen, Kevin A. Ault, Darron R. Brown, Frances B. Alvarez, Jeffrey M. Leiden, Janine T. Bryan, Heather L. Sings and Mark T. Esser. Their work appears in journals such as Vaccine, Gastroenterology, The Journal of Infectious Diseases, Hepatology and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact